BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FGF21
,
glucose metabolic process
,
Obesity
,
Retina
,
Hematopoietic cell
,
Aspirin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
K ras
Summary
General Info
Curated Studies
Most Correlated Studies
Duodenum tissue from high-fat diet fed mice expressing activated K-ras
Uteri of menstruating mice with or without K-ras activation
Gene expression signature associated with K-Ras tumor cell survival
Nutrient-dependent growth of NIH3T3 and NIH3T3 K-ras cell lines
Lung tumors following switch off of tumor inducer mutant K-ras
Explore Curated Studies Results
Literature
Most Relevant Literature
An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: a…
DFT and molecular simulation validation of the binding activity of PDEδ inhibitors for repression of…
SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-…
RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer gro…
Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras
Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patien…
Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells B…
Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS…
FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ